Glucagon-like peptide-1 receptor agonists and risk of prostatic cancer: A systematic review and meta-analysis of randomized controlled trials

To conduct a meta-analysis of randomized clinical trials (RCTs) to investigate whether there is an association between glucagon-like peptide-1 receptor agonist(GLP-1RA) treatment and prostatic cancer.

Publication Details

Journal
Figshare
Published
2025-02-10
DOI
https://doi.org/10.6084/m9.figshare.27600966
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Glucagon-like peptide-1 receptor agonists and risk of prostatic cancer: A systematic review and meta-analysis of randomized controlled trials

Figshare
Diabetes Treatment and Management
article

Glucagon-like peptide-1 receptor agonists and risk of prostatic cancer: A systematic review and meta-analysis of randomized controlled trials

article en

Abstract

To conduct a meta-analysis of randomized clinical trials (RCTs) to investigate whether there is an association between glucagon-like peptide-1 receptor agonist(GLP-1RA) treatment and prostatic cancer.

Figshare
Good health and well-being
Openalex Percentile: Top 41%
Diabetes Treatment and Management
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Glucagon-like peptide-1 receptor agonists and risk of prostatic cancer: A systematic review and meta-analysis of randomized controlled trials · Figshare (2025) | TGRS Research Map | TGRS